Cancer Research Technology
Log in Register
Menu

Anti-MTBP [2C1E11]

Invented at University of Liverpool

Info

Catalogue Number 151708
Applications WB
Antigen/Gene or Protein Targets MTBP
Synonyms MDM2 Binding Protein, MDM2 (Mouse Double Minute 2)-Binding Protein, Mdm2, Transformed 3T3 Cell Double Minute 2, P53 Binding Protein (Mouse) Binding Protein, Mdm2, Transformed 3T3 Cell Double Minute 2, P53 Binding Protein Binding Protein, MDM2BP,
HMTBP
Reactivity Human
Relevance MTBP is an MDM2 binding protein that alters p53/MDM2 homeostasis and may contribute to metastatic suppression. Recent studies have demonstrated that loss of MTBP expression in samples that are p53 positive and have low MDM2 is significantly associated with reduced patient survival in Squamous cell carcinoma of the head and neck (SCCHN).
Host Mouse
Immunogen Recombinant full-length human MTBP
Subclass IgG1 kappa
Notes Clone also known as 14 or T14.
Research Area Cancer, Cell Cycle, Epigenetics & Nuclear Signalling

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Vlatković et al. 2011. Cancer. 117(13):2939-50. PMID: 21692053.

Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.

Europe PMC ID: 21692053


Add a reference

References: 2 entries

Vlatković et al. 2011. Cancer. 117(13):2939-50. PMID: 21692053.

Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor